Dear All, Just below my signature you will find the full details on a recently posted WHO consultancy opportunity. It’s an intriguing 6-month project during which you would be responsible for the rollout and implementation of a new WHO Policy Guidance on the Implementation of Integrated Antimicrobial Stewardship Activities. This guidance will be rolled out in
Dear All, Quick note today as I am both exhausted and exhilarated by having listened to the all-day FDA Advisory committee on the Pfizer/BioNTech COVID vaccine: There is more to learn (the timelines are unlike anything you’ve ever seen before and include a Phase 1-2-3 trial design!!), but the efficacy is impressive and the risk/benefit
Dear All, The Drug-Resistant Infections team at Wellcome Trust (link to their homepage) has launched a survey collecting data on current prescribing practices in low-, middle-, and high-income countries. The survey takes about 15 minutes and seeks answers to these questions: Does the WHO Pathogen Priority List (PPL, link), published in 2015, accurately reflect current pathogen
Dear All, Wow, a news-heavy day … at least two more newsletters this weekend, I think. See below my signature a posting for a 6-month consultancy in Geneva with WHO to support the antimicrobial stewardship activities of the WHO’s Department of Global Coordination and Partnership on Antimicrobial Resistance. Deadline is 10 July 2020 for applications.
Dear All: As you will hopefully recall from November 2019, Theuretzbacher et al. published a review of the preclinical pipeline that summarized data on 407 companies active in the preclinical R&D space during the window Sep 2016 through 1 May 2019. Go here for the newsletter about that paper and go here for my master summary
Dear All, WHO have now released the first version of an antibiotic handbook based specifically on their AWaRe scheme (Access, Watch, Reserve). Here are the links you need: Press release: https://www.who.int/news/item/09-12-2022-moving-who-guidance-on-antibiotics-into-the-heart-of-clinical-practice Book: https://apps.who.int/iris/handle/10665/365237 Just the infographics from the book: https://apps.who.int/iris/handle/10665/365135 We’ve known this was coming based on the draft EML (Essential Medicines List) Antibiotic handbook
Dear All, Continuing on the theme of helping countries develop their own national action plans, WHO released the “WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the human health sector“. The handbook has some great infographics like the one below and will shortly be translated into French, Spanish, and Russian. There
(15 Apr 2021 update: WHO have today released a 2020 update to the report discussed in this newsletter.) Dear All, WHO has today released two exhaustive reviews of the antibacterial R&D universe (and by way of full disclosure, let me say upfront that I participated in the clinical pipeline discussion). Based on a cut-off date
Dear All, In a report entitled Understanding the Antibiotic Manufacturing Ecosystem: A view of global supply chains, pressure points, and implications for antimicrobial resistance response, the Boston Consulting Group and Wellcome Trust have examined at length the questions of (i) how the #FireExtinguishersOfMedicine are made and (ii) how they can be made with the least impact
Dear All: Released just a few hours ago in parallel with the UN General Assembly meetings, WHO has produced a detailed review of the global pipeline. As they note on their overview webpage, “The report found very few potential treatment options for those antibiotic-resistant infections identified by WHO as posing the greatest threat to health, including
